Black Rock Inc. Keros Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,166,010 shares of KROS stock, worth $98.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,166,010

Previous 2,036,788 6.34%

Holding current value

$98.9 Million

Previous $81 Million 77.06%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$41.26 - $70.48 $5.33 Million - $9.11 Million	129,222 Added 6.34%	2,166,010 $143 Million
Q4 2023 Feb 13, 2024	BUY	$27.12 - $41.05 $4.6 Million - $6.96 Million	169,439 Added 9.07%	2,036,788 $81 Million
Q3 2023 Nov 13, 2023	BUY	$31.57 - $43.02 $3.88 Million - $5.29 Million	122,952 Added 7.05%	1,867,349 $59.5 Million
Q2 2023 Aug 11, 2023	BUY	$37.26 - $51.01 $2.5 Million - $3.42 Million	67,137 Added 4.0%	1,744,397 $70.1 Million
Q1 2023 May 12, 2023	BUY	$41.44 - $59.32 $1.61 Million - $2.31 Million	38,934 Added 2.38%	1,677,260 $71.6 Million

Q4 2022 Feb 13, 2023	BUY	$39.45 - $51.77 $6.99 Million - $9.17 Million	177,136 Added 12.12%	1,638,326 $78.7 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $1.8 Million - $2.6 Million	64,847 Added 4.64%	1,461,190 $55 Million
Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $2.56 Million - $6.59 Million	98,297 Added 7.57%	1,396,343 $38.6 Million
Q1 2022 May 12, 2022	BUY	$42.12 - $59.36 $485,222 - $683,827	11,520 Added 0.9%	1,298,046 $70.6 Million
Q4 2021 Feb 10, 2022	BUY	$36.95 - $62.89 $1.93 Million - $3.29 Million	52,368 Added 4.24%	1,286,526 $75.3 Million
Q3 2021 Nov 09, 2021	SELL	$29.27 - $43.71 $152,643 - $227,947	-5,215 Reduced 0.42%	1,234,158 $48.8 Million
Q2 2021 Aug 11, 2021	BUY	$42.4 - $70.11 $52.5 Million - $86.9 Million	1,239,373 New	1,239,373 $52.6 Million

Others Institutions Holding KROS

# of Institutions

153

Shares Held

26.7M

Call Options Held

47.6K

Put Options Held

34.5K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.18B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account